These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 25584892)

  • 1. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.
    McGranahan N; Swanton C
    Cancer Cell; 2015 Jan; 27(1):15-26. PubMed ID: 25584892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
    McGranahan N; Swanton C
    Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome.
    Venkatesan S; Swanton C
    Am Soc Clin Oncol Educ Book; 2016; 35():e141-9. PubMed ID: 27249716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.
    Marusyk A; Janiszewska M; Polyak K
    Cancer Cell; 2020 Apr; 37(4):471-484. PubMed ID: 32289271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational implications of tumor heterogeneity.
    Jamal-Hanjani M; Quezada SA; Larkin J; Swanton C
    Clin Cancer Res; 2015 Mar; 21(6):1258-66. PubMed ID: 25770293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of tumor genetic diversity.
    Mroz EA; Rocco JW
    Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
    Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
    Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
    Swanton C; McGranahan N; Starrett GJ; Harris RS
    Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
    Ling S; Hu Z; Yang Z; Yang F; Li Y; Lin P; Chen K; Dong L; Cao L; Tao Y; Hao L; Chen Q; Gong Q; Wu D; Li W; Zhao W; Tian X; Hao C; Hungate EA; Catenacci DV; Hudson RR; Li WH; Lu X; Wu CI
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6496-505. PubMed ID: 26561581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumor heterogeneity: seeing the wood for the trees.
    Yap TA; Gerlinger M; Futreal PA; Pusztai L; Swanton C
    Sci Transl Med; 2012 Mar; 4(127):127ps10. PubMed ID: 22461637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.
    Hsieh JJ; Manley BJ; Khan N; Gao J; Carlo MI; Cheng EH
    Semin Cell Dev Biol; 2017 Apr; 64():98-106. PubMed ID: 27615548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer: evolution within a lifetime.
    Gerlinger M; McGranahan N; Dewhurst SM; Burrell RA; Tomlinson I; Swanton C
    Annu Rev Genet; 2014; 48():215-36. PubMed ID: 25292359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular heterogeneity and molecular evolution in cancer.
    Almendro V; Marusyk A; Polyak K
    Annu Rev Pathol; 2013 Jan; 8():277-302. PubMed ID: 23092187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Genetic Evolution of Metastasis.
    Rogiers A; Lobon I; Spain L; Turajlic S
    Cancer Res; 2022 May; 82(10):1849-1857. PubMed ID: 35476646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
    El-Deiry WS; Taylor B; Neal JW
    Am Soc Clin Oncol Educ Book; 2017; 37():e8-e15. PubMed ID: 28746017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumor heterogeneity: evolution through space and time.
    Swanton C
    Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constraints in cancer evolution.
    Venkatesan S; Birkbak NJ; Swanton C
    Biochem Soc Trans; 2017 Feb; 45(1):1-13. PubMed ID: 28202655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
    Nijman SMB
    Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary dynamics of intratumor heterogeneity.
    Iwasa Y; Michor F
    PLoS One; 2011 Mar; 6(3):e17866. PubMed ID: 21479218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary Mechanisms of Cancer Suggest Rational Therapeutic Approaches.
    Balzerano A; Paccosi E; Proietti-De-Santis L
    Cytogenet Genome Res; 2021; 161(6-7):362-371. PubMed ID: 34461614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.